Skip to main content
Erschienen in: Pediatric Nephrology 9/2018

17.05.2018 | Original Article

Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study

verfasst von: Vasiliki Karava, Cherine Benzouid, Julien Hogan, Claire Dossier, André Pierre Denjean, Georges Deschênes

Erschienen in: Pediatric Nephrology | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

This study aims to describe the cardiovascular manifestations in children with autosomal dominant polycystic kidney disease (ADPKD) and detect their relation with kidney disease and type of gene mutation.

Methods

Twenty-one patients (7 to 19 years old) were included. Cardiovascular evaluation involved blood pressure (BP), indexed left ventricular mass (LVMI), pulse wave velocity (PWV), and carotid intima media thickness (cIMT) measurement. Patients were classified according to percentile reference values of these parameters in healthy children. The 95th percentile was the highest level of normal values. Glomerular filtration rate (GFR) and microalbuminuria were also measured.

Results

Antihypertensive treatment, large LVMI, high PWV, and increased cIMT were observed in 6 (28.6%), 2 (9.5%), 4 (19%), and 8 (38.1%) patients respectively. Antihypertensive treatment was not associated with either high PWV or increased cIMT. Linear correlation was noticed between LVMI and PWV (r2 = 0.243, p = 0.023) and also between LVMI and cIMT (r2 = 0.203, p = 0.041). The median age of patients with high PWV, increased cIMT, and large LVMI was 9.5, 13, and 18 years old. GFR was normal in all patients. Patients with increased cIMT presented higher levels of urine microalbumin to creatinine ratio (p = 0.025). Genetic mutation was available in 18 patients. Antihypertensive treatment was more frequent in patients without PKD1 missense mutation (p = 0.044).

Conclusions

High PWV and increased cIMT indicating arterial stiffness and hypertrophic vasculopathy may be present in children with ADPKD regardless BP status, and prior to GFR decline, suggesting that vascular disease precedes chronic kidney disease in ADPKD.
Literatur
1.
Zurück zum Zitat Reddy BV, Chapman AB (2017) The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Pediatr Nephrol 32:31–42CrossRefPubMed Reddy BV, Chapman AB (2017) The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Pediatr Nephrol 32:31–42CrossRefPubMed
2.
Zurück zum Zitat Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet (London, England) 369:1287–1301CrossRef Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet (London, England) 369:1287–1301CrossRef
3.
Zurück zum Zitat Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, Heyer CM, Hopp K, Edwards ME, Madsen CD, Mauritz SR, Banks CJ, Baheti S, Reddy B, Herrero JI, Bañales JM, Hogan MC, Tasic V, Watnick TJ, Chapman AB, Vigneau C, Lavainne F, Audrézet MP, Ferec C, Le Meur Y, Torres VE, Genkyst Study Group, HALT Progression of Polycystic Kidney Disease Group; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease, Harris PC (2016) Mutations in GANAB, encoding the glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet 98:1193–1207CrossRefPubMedPubMedCentral Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, Heyer CM, Hopp K, Edwards ME, Madsen CD, Mauritz SR, Banks CJ, Baheti S, Reddy B, Herrero JI, Bañales JM, Hogan MC, Tasic V, Watnick TJ, Chapman AB, Vigneau C, Lavainne F, Audrézet MP, Ferec C, Le Meur Y, Torres VE, Genkyst Study Group, HALT Progression of Polycystic Kidney Disease Group; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease, Harris PC (2016) Mutations in GANAB, encoding the glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet 98:1193–1207CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Chapman AB, Stepniakowski K, Rahbari-Oskoui F (2010) Hypertension in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 17:153–163CrossRefPubMedPubMedCentral Chapman AB, Stepniakowski K, Rahbari-Oskoui F (2010) Hypertension in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 17:153–163CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Griffin MD, Torres VE, Grande JP, Kumar R (1997) Vascular expression of polycystin. J Am Soc Nephrol 8:616–626PubMed Griffin MD, Torres VE, Grande JP, Kumar R (1997) Vascular expression of polycystin. J Am Soc Nephrol 8:616–626PubMed
7.
Zurück zum Zitat Rahman E, Niaz FA, Al-Suwaida A (2009) Analysis of causes of mortality in patients with autosomal dominant polycystic kidney disease: a single center study. Saudi J Kidney Dis Transpl 20:806–810PubMed Rahman E, Niaz FA, Al-Suwaida A (2009) Analysis of causes of mortality in patients with autosomal dominant polycystic kidney disease: a single center study. Saudi J Kidney Dis Transpl 20:806–810PubMed
8.
Zurück zum Zitat Helal I, Reed B, Mettler P, Mc Fann K, Tkachenko O, Yan XD, Schrier RW (2012) Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease. Am J Nephrol 36:362–370CrossRefPubMedPubMedCentral Helal I, Reed B, Mettler P, Mc Fann K, Tkachenko O, Yan XD, Schrier RW (2012) Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease. Am J Nephrol 36:362–370CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Cagnazzo F, Gambacciani C, Morganti R, Perrini P (2017) Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review. Acta Neurochir 159:811–821CrossRefPubMed Cagnazzo F, Gambacciani C, Morganti R, Perrini P (2017) Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review. Acta Neurochir 159:811–821CrossRefPubMed
11.
Zurück zum Zitat Cadnapaphornchai MA, McFann K, Strain JD, Masoumi A, Schrier RW (2008) Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension. Kidney Int 74:1192–1196CrossRefPubMedPubMedCentral Cadnapaphornchai MA, McFann K, Strain JD, Masoumi A, Schrier RW (2008) Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension. Kidney Int 74:1192–1196CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ivy DD, Shaffer EM, Johnson AM, Kimberling WJ, Dobin A, Gabow PA (1995) Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:2032–2036PubMed Ivy DD, Shaffer EM, Johnson AM, Kimberling WJ, Dobin A, Gabow PA (1995) Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:2032–2036PubMed
13.
Zurück zum Zitat Thong KM, Ong ACM (2014) Sudden death due to subarachnoid haemorrhage in an infant with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 29(Suppl 4):121–123CrossRef Thong KM, Ong ACM (2014) Sudden death due to subarachnoid haemorrhage in an infant with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 29(Suppl 4):121–123CrossRef
14.
Zurück zum Zitat Kubo S, Nakajima M, Fukuda K, Nobayashi M, Sakaki T, Aoki K, Hirao Y, Yoshioka A (2004) A 4-year-old girl with autosomal dominant polycystic kidney disease complicated by a ruptured intracranial aneurysm. Eur J Pediatr 163:675–677PubMed Kubo S, Nakajima M, Fukuda K, Nobayashi M, Sakaki T, Aoki K, Hirao Y, Yoshioka A (2004) A 4-year-old girl with autosomal dominant polycystic kidney disease complicated by a ruptured intracranial aneurysm. Eur J Pediatr 163:675–677PubMed
15.
Zurück zum Zitat Wang M-C, Tsai W-C, Chen J-Y, Cheng MF, Huang JJ (2007) Arterial stiffness correlated with cardiac remodelling in patients with chronic kidney disease. Nephrology 12:591–597CrossRefPubMed Wang M-C, Tsai W-C, Chen J-Y, Cheng MF, Huang JJ (2007) Arterial stiffness correlated with cardiac remodelling in patients with chronic kidney disease. Nephrology 12:591–597CrossRefPubMed
16.
Zurück zum Zitat Chung CM, Lin YS, Chu CM, Chang ST, Cheng HW, Yang TY, Hsiao JF, Pan KL, Hsu JT (2012) Arterial stiffness is the independent factor of left ventricular hypertrophy determined by electrocardiogram. Am J Med Sci 344:190–193CrossRefPubMed Chung CM, Lin YS, Chu CM, Chang ST, Cheng HW, Yang TY, Hsiao JF, Pan KL, Hsu JT (2012) Arterial stiffness is the independent factor of left ventricular hypertrophy determined by electrocardiogram. Am J Med Sci 344:190–193CrossRefPubMed
17.
Zurück zum Zitat Ikonomidis I, Lekakis J, Papadopoulos C, Triantafyllidi H, Paraskevaidis I, Georgoula G, Tzortzis S, Revela I, Kremastinos DT (2008) Incremental value of pulse wave velocity in the determination of coronary microcirculatory dysfunction in never-treated patients with essential hypertension. Am J Hypertens 21:806–813CrossRefPubMed Ikonomidis I, Lekakis J, Papadopoulos C, Triantafyllidi H, Paraskevaidis I, Georgoula G, Tzortzis S, Revela I, Kremastinos DT (2008) Incremental value of pulse wave velocity in the determination of coronary microcirculatory dysfunction in never-treated patients with essential hypertension. Am J Hypertens 21:806–813CrossRefPubMed
18.
Zurück zum Zitat Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness. J Am Coll Cardiol 55:1318–1327CrossRefPubMed Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness. J Am Coll Cardiol 55:1318–1327CrossRefPubMed
19.
Zurück zum Zitat Tarumi T, Shah F, Tanaka H, Haley AP (2011) Association between central elastic artery stiffness and cerebral perfusion in deep subcortical gray and white matter. Am J Hypertens 24:1108–1113CrossRefPubMed Tarumi T, Shah F, Tanaka H, Haley AP (2011) Association between central elastic artery stiffness and cerebral perfusion in deep subcortical gray and white matter. Am J Hypertens 24:1108–1113CrossRefPubMed
20.
Zurück zum Zitat Bonithon-Kopp C, Touboul PJ, Berr C, Leroux C, Mainard F, Courbon D, Ducimetière P (1996) Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol 16:310–316CrossRefPubMed Bonithon-Kopp C, Touboul PJ, Berr C, Leroux C, Mainard F, Courbon D, Ducimetière P (1996) Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol 16:310–316CrossRefPubMed
21.
Zurück zum Zitat Nezu T, Hosomi N, Aoki S, Matsumoto M (2016) Carotid intima-media thickness for atherosclerosis. J Atheroscler Thromb 23:18–31CrossRefPubMed Nezu T, Hosomi N, Aoki S, Matsumoto M (2016) Carotid intima-media thickness for atherosclerosis. J Atheroscler Thromb 23:18–31CrossRefPubMed
22.
Zurück zum Zitat Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459–467CrossRefPubMed Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459–467CrossRefPubMed
23.
Zurück zum Zitat Rong S, Jin X, Ye C, Chen J, Mei C (2009) Carotid vascular remodelling in patients with autosomal dominant polycystic kidney disease. Nephrology 14:113–117CrossRefPubMed Rong S, Jin X, Ye C, Chen J, Mei C (2009) Carotid vascular remodelling in patients with autosomal dominant polycystic kidney disease. Nephrology 14:113–117CrossRefPubMed
24.
Zurück zum Zitat Turkmen K, Oflaz H, Uslu B, Cimen AO, Elitok A, Kasikcioglu E, Alisir S, Tufan F, Namli S, Uysal M, Ecder T (2008) Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries. Clin J Am Soc Nephrol 3:986–991CrossRefPubMedPubMedCentral Turkmen K, Oflaz H, Uslu B, Cimen AO, Elitok A, Kasikcioglu E, Alisir S, Tufan F, Namli S, Uysal M, Ecder T (2008) Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries. Clin J Am Soc Nephrol 3:986–991CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Kocaman O, Oflaz H, Yekeler E, Dursun M, Erdogan D, Demirel S, Alisir S, Turgut F, Mercanoglu F, Ecder T (2004) Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 43:854–860CrossRefPubMed Kocaman O, Oflaz H, Yekeler E, Dursun M, Erdogan D, Demirel S, Alisir S, Turgut F, Mercanoglu F, Ecder T (2004) Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 43:854–860CrossRefPubMed
26.
Zurück zum Zitat Nowak KL, Farmer H, Cadnapaphornchai MA, Gitomer B, Chonchol M (2017) Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 32:342–347CrossRefPubMed Nowak KL, Farmer H, Cadnapaphornchai MA, Gitomer B, Chonchol M (2017) Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 32:342–347CrossRefPubMed
27.
Zurück zum Zitat Shroff R, Dégi A, Kerti A, Kis E, Cseprekál O, Tory K, Szabó AJ, Reusz GS (2013) Cardiovascular risk assessment in children with chronic kidney disease. Pediatr Nephrol 28:875–884CrossRefPubMed Shroff R, Dégi A, Kerti A, Kis E, Cseprekál O, Tory K, Szabó AJ, Reusz GS (2013) Cardiovascular risk assessment in children with chronic kidney disease. Pediatr Nephrol 28:875–884CrossRefPubMed
28.
Zurück zum Zitat Lowenthal A, Evans JMA, Punn R, Nourse SE, Vu CN, Popat RA, Selamet Tierney ES (2014) Arterial applanation tonometry: feasibility and reproducibility in children and adolescents. Am J Hypertens 27:1218–1224CrossRefPubMedPubMedCentral Lowenthal A, Evans JMA, Punn R, Nourse SE, Vu CN, Popat RA, Selamet Tierney ES (2014) Arterial applanation tonometry: feasibility and reproducibility in children and adolescents. Am J Hypertens 27:1218–1224CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Narayan O, Casan J, Szarski M, Dart AM, Meredith IT, Cameron JD (2014) Estimation of central aortic blood pressure: a systematic meta-analysis of available techniques. J Hypertens 32:1727–1740CrossRefPubMed Narayan O, Casan J, Szarski M, Dart AM, Meredith IT, Cameron JD (2014) Estimation of central aortic blood pressure: a systematic meta-analysis of available techniques. J Hypertens 32:1727–1740CrossRefPubMed
30.
Zurück zum Zitat McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson IB (2014) Central blood pressure: current evidence and clinical importance. Eur Heart J 35:1719–1725CrossRefPubMedPubMedCentral McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson IB (2014) Central blood pressure: current evidence and clinical importance. Eur Heart J 35:1719–1725CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Doyon A, Kracht D, Bayazit AK, Deveci M, Duzova A, Krmar RT, Litwin M, Niemirska A, Oguz B, Schmidt BM, Sözeri B, Querfeld U, Melk A, Schaefer F, Wühl E, 4C Study Consortium (2013) Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertension 62:550–556CrossRefPubMed Doyon A, Kracht D, Bayazit AK, Deveci M, Duzova A, Krmar RT, Litwin M, Niemirska A, Oguz B, Schmidt BM, Sözeri B, Querfeld U, Melk A, Schaefer F, Wühl E, 4C Study Consortium (2013) Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertension 62:550–556CrossRefPubMed
32.
Zurück zum Zitat Reusz GS, Cseprekal O, Temmar M, Kis E, Cherif AB, Thaleb A, Fekete A, Szabó AJ, Benetos A, Salvi P (2010) Reference values of pulse wave velocity in healthy children and teenagers. Hypertension 56:217–224CrossRefPubMed Reusz GS, Cseprekal O, Temmar M, Kis E, Cherif AB, Thaleb A, Fekete A, Szabó AJ, Benetos A, Salvi P (2010) Reference values of pulse wave velocity in healthy children and teenagers. Hypertension 56:217–224CrossRefPubMed
33.
Zurück zum Zitat Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22:709–714CrossRefPubMed Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22:709–714CrossRefPubMed
34.
Zurück zum Zitat Flynn JT, Daniels SR, Hayman LL, Maahs DM, BW MC, Mitsnefes M, Zachariah JP, Urbina EM, American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young (2014) Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertenssion 63:1116–1135CrossRef Flynn JT, Daniels SR, Hayman LL, Maahs DM, BW MC, Mitsnefes M, Zachariah JP, Urbina EM, American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young (2014) Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertenssion 63:1116–1135CrossRef
35.
Zurück zum Zitat Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedPubMedCentral Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Huang CM, Wang KL, Cheng HM, Chuang SY, Sung SH, Yu WC, Ting CT, Lakatta EG, Yin FC, Chou P, Chen CH (2011) Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities. J Hypertens 29:454–459CrossRefPubMedPubMedCentral Huang CM, Wang KL, Cheng HM, Chuang SY, Sung SH, Yu WC, Ting CT, Lakatta EG, Yin FC, Chou P, Chen CH (2011) Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities. J Hypertens 29:454–459CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Rouxinol-Dias A, Araújo S, Silva JA, Barbosa L, Polónia J (2017) Association between ambulatory blood pressure values and central aortic pressure in a large population of normotensive and hypertensive patients. Blood Press Monit 23:24–32 Rouxinol-Dias A, Araújo S, Silva JA, Barbosa L, Polónia J (2017) Association between ambulatory blood pressure values and central aortic pressure in a large population of normotensive and hypertensive patients. Blood Press Monit 23:24–32
39.
Zurück zum Zitat Rahman M, Hsu JY, Desai N, Hsu CY, Anderson AH, Appel LJ, Chen J, Cohen DL, Drawz PE, He J, Qiang P, Ricardo AC, Steigerwalt S, Weir MR, Wright JT Jr, Zhang X, Townsend RR, Study Investigators CRIC (2018) Central blood pressure and cardiovascular outcomes in chronic kidney disease. Clin J Am Soc Nephrol. https://doi.org/10.2215/CJN.08620817 Rahman M, Hsu JY, Desai N, Hsu CY, Anderson AH, Appel LJ, Chen J, Cohen DL, Drawz PE, He J, Qiang P, Ricardo AC, Steigerwalt S, Weir MR, Wright JT Jr, Zhang X, Townsend RR, Study Investigators CRIC (2018) Central blood pressure and cardiovascular outcomes in chronic kidney disease. Clin J Am Soc Nephrol. https://​doi.​org/​10.​2215/​CJN.​08620817
40.
Zurück zum Zitat Michel J-B (2004) Système rénine-angiotensine et remodelage vasculaire. Médecine/sciences 20:409–413CrossRef Michel J-B (2004) Système rénine-angiotensine et remodelage vasculaire. Médecine/sciences 20:409–413CrossRef
41.
Zurück zum Zitat Touyz RM (2005) Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 90:449–455CrossRefPubMed Touyz RM (2005) Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 90:449–455CrossRefPubMed
42.
Zurück zum Zitat Ashor AW, Lara J, Siervo M, Celis-Morales C, Mathers JC (2014) Effects of exercise modalities on arterial stiffness and wave reflection: a systematic review and meta-analysis of randomized controlled trials. PLoS One 9:e110034CrossRefPubMedPubMedCentral Ashor AW, Lara J, Siervo M, Celis-Morales C, Mathers JC (2014) Effects of exercise modalities on arterial stiffness and wave reflection: a systematic review and meta-analysis of randomized controlled trials. PLoS One 9:e110034CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat D’Elia L, Galletti F, La Fata E, Sabino P, Strazzullo P (2017) Effect of dietary sodium restriction on arterial stiffness. J Hypertens 36:734–743CrossRef D’Elia L, Galletti F, La Fata E, Sabino P, Strazzullo P (2017) Effect of dietary sodium restriction on arterial stiffness. J Hypertens 36:734–743CrossRef
44.
Zurück zum Zitat Petersen KS, Clifton PM, Keogh JB (2014) The association between carotid intima media thickness and individual dietary components and patterns. Nutr Metab Cardiovasc Dis 24:495–502CrossRefPubMed Petersen KS, Clifton PM, Keogh JB (2014) The association between carotid intima media thickness and individual dietary components and patterns. Nutr Metab Cardiovasc Dis 24:495–502CrossRefPubMed
45.
Zurück zum Zitat Meyer AA, Kundt G, Lenschow U, Schuff-Werner P, Kienast W (2006) Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. J Am Coll Cardiol 48:1865–1870CrossRefPubMed Meyer AA, Kundt G, Lenschow U, Schuff-Werner P, Kienast W (2006) Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. J Am Coll Cardiol 48:1865–1870CrossRefPubMed
46.
Zurück zum Zitat Cadnapaphornchai MA, McFann K, Strain JD, Masoumi A, Schrier RW (2009) Prospective change in renal volume and function in children with ADPKD. Clin J Am Soc Nephrol 4:820–829CrossRefPubMedPubMedCentral Cadnapaphornchai MA, McFann K, Strain JD, Masoumi A, Schrier RW (2009) Prospective change in renal volume and function in children with ADPKD. Clin J Am Soc Nephrol 4:820–829CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Cornec-Le Gall E, Audrezet M-P, Rousseau A, Hourmant M, Renaudineau E, Charasse C, Morin MP, Moal MC, Dantal J, Wehbe B, Perrichot R, Frouget T, Vigneau C, Potier J, Jousset P, Guillodo MP, Siohan P, Terki N, Sawadogo T, Legrand D, Menoyo-Calonge V, Benarbia S, Besnier D, Longuet H, Férec C, Le Meur Y (2016) The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 27:942–951CrossRefPubMed Cornec-Le Gall E, Audrezet M-P, Rousseau A, Hourmant M, Renaudineau E, Charasse C, Morin MP, Moal MC, Dantal J, Wehbe B, Perrichot R, Frouget T, Vigneau C, Potier J, Jousset P, Guillodo MP, Siohan P, Terki N, Sawadogo T, Legrand D, Menoyo-Calonge V, Benarbia S, Besnier D, Longuet H, Férec C, Le Meur Y (2016) The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 27:942–951CrossRefPubMed
48.
Zurück zum Zitat Woon C, Bielinski-Bradbury A, O’Reilly K, Robinson P (2015) A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease. BMC Nephrol 16:140CrossRefPubMedPubMedCentral Woon C, Bielinski-Bradbury A, O’Reilly K, Robinson P (2015) A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease. BMC Nephrol 16:140CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Azurmendi PJ, Fraga AR, Galan FM, Kotliar C, Arrizurieta EE, Valdez MG, Forcada PJ, Stefan JS, Martin RS (2009) Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function. Nephrol Dial Transplant 24:2458–2463CrossRefPubMed Azurmendi PJ, Fraga AR, Galan FM, Kotliar C, Arrizurieta EE, Valdez MG, Forcada PJ, Stefan JS, Martin RS (2009) Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function. Nephrol Dial Transplant 24:2458–2463CrossRefPubMed
50.
Zurück zum Zitat Cornec-Le Gall E, Audrézet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall-Jezequel A, Saliou P, Férec C, Le Meur Y (2013) Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 24:1006–1013CrossRefPubMedPubMedCentral Cornec-Le Gall E, Audrézet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall-Jezequel A, Saliou P, Férec C, Le Meur Y (2013) Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 24:1006–1013CrossRefPubMedPubMedCentral
Metadaten
Titel
Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study
verfasst von
Vasiliki Karava
Cherine Benzouid
Julien Hogan
Claire Dossier
André Pierre Denjean
Georges Deschênes
Publikationsdatum
17.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 9/2018
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-018-3964-9

Weitere Artikel der Ausgabe 9/2018

Pediatric Nephrology 9/2018 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.